Vol.53 No.S-3 December 2005
In vitro and in vivo antibacterial activity of moxifloxacin, a novel quinolone antibacterial agent
Jpn. J. Chemother. 53 (S-3): 1-15, 2005
In vitro antibacterial activity of moxifloxacin
Jpn. J. Chemother. 53 (S-3): 16-20, 2005
In vitro antibacterial activity of moxifloxacin against anaerobic and facultative bacteria
Jpn. J. Chemother. 53 (S-3): 21-26, 2005
Phase III double-blind comparative study of BAY 12-8039 (moxifloxacin) versus levofloxacin in patients with community-acquired pneumonia
Jpn. J. Chemother. 53 (S-3): 27-46, 2005
Phase III clinical study of BAY 12-8039 (moxifloxacin) for respiratory tract infections
Jpn. J. Chemother. 53 (S-3): 47-59, 2005
BAY 12-8039 (moxifloxacin) Phase III study for the treatment of skin and skin structure infections
Jpn. J. Chemother. 53 (S-3): 60-73, 2005